F772 in Oregon. Pick another state for the same tag.
Against expectation — 2024
Oregon cites F772 more often than its own record predicts
Versus expected share4.85×
4.85 times the share F772 takes of citations nationally.
Share of Oregon citations0.08%
Of every deficiency written in Oregon in 2024, this is the portion that was F772.
Oregon0.08%
National0.02%
Share of all citations that were F772.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Oregon surveyors wrote
F772 findings written in Oregon, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedSeptember 27, 2024
Based on interview and record review it was determined the facility failed to ensure a blood sample was obtained for 1 of 1 sampled resident (#21) reviewed for laboratory tests. This placed residents at risk for delayed treatment. Findings include:
Resident 21 was admitted to the facility in 4/2023 with a diagnosis of a stroke.
A 7/2024 TAR revealed on 7/10/24 staff were to obtain a blood sample for blood chemistry.
Resident 33's record did not have blood chemistry results.
On 9/25/24 at 1:58 PM a request was made to Staff 2 (DNS) and Staff 24 (LPN IP) to provide laboratory results. No additional information was provided.
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction